2000q1 Archives by Author

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...

Starting: Thu Jan 6 16:28:13 2000
Ending: Tue Feb 22 14:34:18 2000
Messages: 111

• [Pharm-policy] Full Text of Al Gore's speech before the UN Security Council on AIDS in Afica Thiru Balasubramaniam
• [Pharm-policy] WHO supports compulsory licensing of expensive drugs Thiru Balasubramaniam
• [Pharm-policy] Dominican Republic IPR legislation Thiru Balasubramaniam
• [Pharm-policy] Dominican IPR legislation (compulsory licensing sections) Thiru Balasubramaniam
• [Pharm-policy] Salon interview with Dr. Ian Roberts Thiru Balasubramaniam
• [Pharm-policy] (no subject) RICARDO JULIAN ROJAS ESTUPINAN
• [Pharm-policy] RE: [Ip-health] Nafta and parallel imports Kasper, Toby
• [Pharm-policy] RE: [Ip-health] TACD statement on Access to Medicines in Developi ng Countries Kasper, Toby
• [Pharm-policy] RE: [Ip-health] New argument in favor of Bolar-Roche provision Kasper, Toby
• [Pharm-policy] SA/Germany March 10, 1998 Cape Town meeting on SA Medicines Act James Love
• [Pharm-policy] Today's WP editorial James Love
• [Pharm-policy] Getting information on US policy from agencies James Love
• [Pharm-policy] letter to Dr. Novotny regarding empirical basis for trade policy James Love
• [Pharm-policy] Rep. Berry's web page on pharmacuetical drugs James Love
• [Pharm-policy] Other Congressional web sites on pharmaceutical drugs James Love
• [Pharm-policy] letter to Dr. Novotny regarding empirical basis for trade policy James Love
• [Pharm-policy] The R&D Tax Credit and Industry Spending on R&D James Love
• [Pharm-policy] Today's annoucement by Gore on HIV/AIDS initiative James Love
• [Pharm-policy] Nafta and parallel imports James Love
• [Pharm-policy] Rep. Jessie Jackson, Jr. on Gore speech on HIV/AIDS James Love
• [Pharm-policy] PhRMA's Dec 3, 1999 NTE submission James Love
• [Pharm-policy] PhRMA's Dec 3, 1999 NTE submission: Dominican Republic James Love
• [Pharm-policy] PhRMA NTE submissions is for Australia James Love
• [Pharm-policy] PhRMA claims South Africa government agreed to delay in litigation over Medicines Act James Love
• [Pharm-policy] PhRMA's Dec 3, 1999 Thailand NTE submissions James Love
• [Pharm-policy] PhRMA on generic perscribing in Indonesia James Love
• [Pharm-policy] Brazil decree on compulsory licensing in cases of national emergency James Love
• [Pharm-policy] PhRMA says Mexico generic persscribing law has been "rectified" James Love
• [Pharm-policy] Typo in URL for Domincan Republic NTE submission James Love
• [Pharm-policy] African perspectives on funding for HIV treatments James Love
• [Pharm-policy] article on PTO's new proposed guidelines for DNA patents James Love
• [Pharm-policy] National Academies: IPRs, who far should they be extended? James Love
• [Pharm-policy] January 12, 2000 meeting with USTR, DHHS, and USPTO James Love
• [Pharm-policy] January 12, 2000 USTR, USPTO, DHHS meeting (formatting fixed) James Love
• [Pharm-policy] TACD statement on Access to Medicines in Developing Countries James Love
• [Pharm-policy] Pierre Chirac and Richard Laing exchange regarding WHO EDL James Love
• [Pharm-policy] Projected World Pharmaceutical Market by Year 2002 James Love
• [Pharm-policy] Big PhRMA putting gene info in Public Domain James Love
• [Pharm-policy] Arianna Huffington: Cheap Talk At The United Nations James Love
• [Pharm-policy] MSF press release on Thai ddI case James Love
• [Pharm-policy] Terbes Agreement and Compulsory licensing artice James Love
• [Pharm-policy] Draft statement on early working of pharmacuetical patents James Love
• [Pharm-policy] Demo outside US Embasssy in Bangkok James Love
• [Pharm-policy] TACD draft position on transparency and economic data James Love
• [Pharm-policy] US government and Industry R&D expenditures compared, 1991 to 1994 James Love
• [Pharm-policy] Bill Hennessey article on TRIPS James Love
• [Pharm-policy] US Talking Points on Thai ddi CL James Love
• [Pharm-policy] Transparency and Government Contracts James Love
• [Pharm-policy] New argument in favor of Bolar-Roche provision James Love
• [Pharm-policy] US Government Use of Patents and Reasonable Royalty Rates James Love
• [Pharm-policy] David Banta in JAMA James Love
• [Pharm-policy] Thai ddI / letter to Rosshirt James Love
• [Pharm-policy] Rosshirt letter - date fixed James Love
• [Pharm-policy] TACD: draft Health Registration Data Exclusivity statement James Love
• [Pharm-policy] Canada to win early working - but lose on stockpiling James Love
• [Pharm-policy] (no subject) James Love
• [Pharm-policy] Canada decision and 27.1 issue James Love
• [Pharm-policy] US pressure in Dominican Republic Patent dispute James Love
• [Pharm-policy] Query to USTR on DR dispute James Love
• [Pharm-policy] Martin Frid on Alexis de Tocqueville Institution James Love
• [Pharm-policy] USA seeks to remove IPR section from AIDS resolution at WHO James Love
• [Pharm-policy] More on USG at WHO meeting James Love
• [Pharm-policy] CI statement to WHA EB James Love
• [Pharm-policy] WHO drafting group meetings at Lunch today James Love
• [Pharm-policy] WHO/IFPMA Round Table Report James Love
• [Pharm-policy] PhRMA press release on TACD statement on R&D James Love
• [Pharm-policy] R*D Cost, by component James Love
• [Pharm-policy] PhRMA's backgrounder on draft TACD R&D statement James Love
• [Pharm-policy] Jim Keon on Canada/EU/WTO dispute and Article 27.1 James Love
• [Pharm-policy] lack of transparency at NIH on patent licenses James Love
• [Pharm-policy] USTR sends new letter to Thailand - decision on CL is "one for Thailand to make" James Love
• [Pharm-policy] Dr. Thomas Novotny's response regarding WHA Executive Board meeting James Love
• [Pharm-policy] Letter from Thai Academics to USTR regarding PhRMA NTE submissions James Love
• [Pharm-policy] HAI on WHO-EB HIV/AIDS resolution James Love
• [Pharm-policy] Reply to Dr. Novotny James Love
• [Pharm-policy] Greg Perry on EU and Health Registration Data James Love
• [Pharm-policy] Treatments low spread of AIDS James Love
• [Pharm-policy] Michael Hirsh: Has the White House Really Changed Its Tune on AIDS Drugs?, James Love
• [Pharm-policy] Michael Hirsh's Newsweek.com story James Love
• [Pharm-policy] Stephens and Strauss: CDC misled Congress on spending James Love
• [Pharm-policy] Bangkok Post: Compulsory ddI licensing seen unlikely James Love
• [Pharm-policy] National Academies Workshop - starts today James Love
• [Pharm-policy] 3 more Thai articles James Love
• [Pharm-policy] Allocation of R&D costs, the 1991 DiMasi study James Love
• [Pharm-policy] fixed: Allocation of R&D costs, the 1991 DiMasi study James Love
• [Pharm-policy] BMS says it will sue in Thailand over generic production of d4T James Love
• [Pharm-policy] Blue Book URL James Love
• [Pharm-policy] Note on d4T James Love
• [Pharm-policy] fy 2001 NIH budget is $19 billion James Love
• [Pharm-policy] 2 Articles from Science James Love
• [Pharm-policy] Development of Stavudine (d4T) James Love
• [Pharm-policy] Robert Fitts Jan 28 letter to Thai government James Love
• [Pharm-policy] Satellife, e-drug, healthnet.org domain dispute James Love
• [Pharm-policy] Conference on Africa Trade bill James Love
• [Pharm-policy] (no subject) James Love
• [Pharm-policy] Thai call for self reliance on drug production at UNCTAD meeting James Love
• [Pharm-policy] Annual costs of HIV/AIDS drugs, at US wholesale prices James Love
• [Pharm-policy] TACD recommendations on Pharmaceuticals and IP James Love
• [Pharm-policy] Far Eastern Economic Review on UNCTAD meeting and Thai CL dispute James Love
• [Pharm-policy] US law on TRIPS plus James Love
• [Pharm-policy] EU position in 1998 on RDS James Love
• [Pharm-policy] Hillary Clinton endorses parallel imports of medicine for USA James Love
• [Pharm-policy] SENATORS TO HOST DISCUSSIONS ON PATENT LAW James Love
• [Pharm-policy] Patent on CCR5 protein James Love
• [Pharm-policy] PhRMA Feb 18, 2000 301 submissions James Love
• [Pharm-policy] Daley asks Brazil to derogate decree on complusory licensing James Love
• [Pharm-policy] Global Health Council/Legislation on funding international health James Love
• [Pharm-policy] unsubscribe MichaelT1
• [Pharm-policy] unsubscribe MichaelT1
• [Pharm-policy] Re: [Ip-health] New argument in favor of Bolar-Roche provision Eric Sawyer
• [Pharm-policy] APARTHEID OF PHARMACOLOGY - Le Monde diplomatique (fwd) Robert Weissman

Last message date: Tue Feb 22 14:34:18 2000
Archived on: Tue Feb 22 09:34:20 2000

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...